Companies / BOC Sciences / Belantamab
BOC Sciences

Belantamab | BOC Sciences

Belantamab is a humanized monoclonal antibody directed against the B-cell maturation antigen (BCMA). Belantamab can be used in the synthesis of Belantamab mafodotin, an ADC developed for the treatment of adult patients with relapsed or refractory multiple myeloma (RRMM).

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.